drugset / Trial / NCT02689063

Maxigesic IV Phase 3 Bunionectomy Study

NCT02689063

Phase 3 Completed 276 enrolled AFT Pharmaceuticals, Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy

Timeline

Start
2016-10-26
Primary completion
2017-06-30
Completion
2017-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1000 mg Intravenous
Comparator Ibuprofen Small molecule 300 mg Intravenous

Indications

No indication recorded.